Purpose Activation of coagulation and fibrinolysis is frequently found among cancer patients.
Such tumors are considered to be associated with a higher risk of invasion, metastases, and …

Purpose Activated coagulation and fibrinolytic system in cancer patients is associated with
tumor stroma formation and metastasis in different cancer types. The aim of this study is to …

Objectives: Activation of coagulation and fibrinolysis is frequently observed in patients with
cancer, even with absence of thrombosis. Furthermore, plasma coagulation parameters …

Background. Cancer is one of the most common acquired causes of venous
thromboembolism. Aim. To evaluate haemostasis disorders in patients with non-metastatic …

Activated coagulation and fibrinolytic system in cancer patients is associated with tumor
stroma formation and metastasis in different cancer types. The aim of this study is to explore …

Background Systemic hemostasis and thrombosis activation has been implicated in tumor
progression and metastasis. This study aimed to investigate the use of coagulation factors …

Background Hypercoagulation is associated with tumor progression and metastasis in
various types of malignancy. We compared the prognostic value of preoperative plasma …

Thirty-six patients with nonmucinous adenocarcinoma of the stomach, candidates for
surgical laparotomy, were studied to evaluate the presence and extent of coagulation …

Activation of coagulation and fibrinolysis is frequently encountered among cancer patients.
Such tumors are supposed to be associated with higher risk of invasion, metastases and …

Objective Gastric cancer (GC) is one of the most common malignant tumors in the world, and
its incidence rate ranks the fourth in the world. Hyperfibrinogenemia and …